Item Type | Name |
Concept
|
Global Burden of Disease
|
Concept
|
Clinical Decision-Making
|
Concept
|
Abdomen
|
Concept
|
Rivaroxaban
|
Concept
|
Dabigatran
|
Concept
|
Accreditation
|
Concept
|
ADAMTS13 Protein
|
Concept
|
Administration, Oral
|
Concept
|
Adolescent
|
Concept
|
Contraindications
|
Concept
|
Adult
|
Concept
|
Aerosols
|
Concept
|
Aftercare
|
Concept
|
Angiography
|
Concept
|
Animals
|
Concept
|
Age Factors
|
Concept
|
Aged
|
Concept
|
Aged, 80 and over
|
Concept
|
Aging
|
Concept
|
Anticoagulants
|
Concept
|
Antihypertensive Agents
|
Concept
|
Antineoplastic Combined Chemotherapy Protocols
|
Concept
|
Algorithms
|
Concept
|
Antithrombin III
|
Concept
|
Antithrombins
|
Concept
|
Ambulatory Care
|
Concept
|
Canada
|
Concept
|
Acute Disease
|
Concept
|
Cardiography, Impedance
|
Concept
|
Cardiomyopathy, Dilated
|
Concept
|
Blindness
|
Concept
|
Blood Circulation
|
Concept
|
Blood Coagulation
|
Concept
|
Blood Coagulation Factors
|
Concept
|
Blood Coagulation Tests
|
Concept
|
Blood Gas Analysis
|
Concept
|
Blood Transfusion
|
Concept
|
Body Weight
|
Concept
|
Bone and Bones
|
Concept
|
Bone Marrow
|
Concept
|
Bone Marrow Examination
|
Concept
|
Cardiovascular Diseases
|
Concept
|
Bayes Theorem
|
Concept
|
Catheterization, Central Venous
|
Concept
|
Cause of Death
|
Concept
|
Benzamides
|
Concept
|
Benzimidazoles
|
Concept
|
Bronchiectasis
|
Concept
|
Beverages
|
Concept
|
Computer Simulation
|
Concept
|
Decision Making
|
Concept
|
Decision Support Techniques
|
Concept
|
Biopsy, Needle
|
Concept
|
Biotin
|
Concept
|
Community Participation
|
Concept
|
Chronic Disease
|
Concept
|
Coronary Disease
|
Concept
|
Cost-Benefit Analysis
|
Concept
|
Cost Control
|
Concept
|
Costs and Cost Analysis
|
Concept
|
Creatinine
|
Concept
|
Cross-Sectional Studies
|
Concept
|
Clinical Protocols
|
Concept
|
Clinical Trials as Topic
|
Concept
|
Dextrans
|
Concept
|
Europe
|
Concept
|
Evaluation Studies as Topic
|
Concept
|
Combined Modality Therapy
|
Concept
|
Communication
|
Concept
|
Factor V
|
Concept
|
Factor X
|
Concept
|
Factor XI
|
Concept
|
False Positive Reactions
|
Concept
|
Female
|
Concept
|
Femoral Vein
|
Concept
|
Dose-Response Relationship, Drug
|
Concept
|
Double-Blind Method
|
Concept
|
Drug Administration Schedule
|
Concept
|
Fever
|
Concept
|
Fibrin Fibrinogen Degradation Products
|
Concept
|
Fibrinogen
|
Concept
|
Fibrinolytic Agents
|
Concept
|
Drug Evaluation
|
Concept
|
Drug Hypersensitivity
|
Concept
|
Drug Therapy, Combination
|
Concept
|
Drug Utilization
|
Concept
|
Nonprescription Drugs
|
Concept
|
Electrocardiography
|
Concept
|
Hip
|
Concept
|
Hip Fractures
|
Concept
|
Hip Joint
|
Concept
|
Hip Prosthesis
|
Concept
|
Hirudins
|
Concept
|
Home Care Services
|
Concept
|
Health Facilities
|
Concept
|
Medicare
|
Concept
|
Hospitalization
|
Concept
|
Hospitals, Community
|
Concept
|
Embolism
|
Concept
|
Emergencies
|
Concept
|
Emergency Medical Services
|
Concept
|
Health Planning Guidelines
|
Concept
|
Health Promotion
|
Concept
|
Health Services Research
|
Concept
|
Heart Aneurysm
|
Concept
|
Hospitals, University
|
Concept
|
Humans
|
Concept
|
Gastrointestinal Neoplasms
|
Concept
|
Cardiac Catheterization
|
Concept
|
Heart Diseases
|
Concept
|
Heart Neoplasms
|
Concept
|
Heart Valve Prosthesis
|
Concept
|
Heart Valves
|
Concept
|
Hematologic Diseases
|
Concept
|
Hematologic Tests
|
Concept
|
Hematuria
|
Concept
|
Hemolytic-Uremic Syndrome
|
Concept
|
Hemorrhage
|
Concept
|
Gastrointestinal Hemorrhage
|
Concept
|
Hemostasis
|
Concept
|
Heparin
|
Concept
|
Heparin, Low-Molecular-Weight
|
Concept
|
Glucocorticoids
|
Concept
|
Kidney
|
Concept
|
Long-Term Care
|
Concept
|
Longitudinal Studies
|
Concept
|
Kidney Diseases
|
Concept
|
Kidney Function Tests
|
Concept
|
Lung
|
Concept
|
Knee
|
Concept
|
Knee Joint
|
Concept
|
Knee Prosthesis
|
Concept
|
Health Knowledge, Attitudes, Practice
|
Concept
|
Laboratories
|
Concept
|
Magnetic Resonance Imaging
|
Concept
|
Government Agencies
|
Concept
|
Male
|
Concept
|
United Kingdom
|
Concept
|
Information Systems
|
Concept
|
Infusions, Intravenous
|
Concept
|
Leg
|
Concept
|
Infusions, Parenteral
|
Concept
|
Injections, Intravenous
|
Concept
|
Injections, Subcutaneous
|
Concept
|
Inpatients
|
Concept
|
Length of Stay
|
Concept
|
Muscular Diseases
|
Concept
|
Intensive Care Units
|
Concept
|
Mutation
|
Concept
|
Myocardial Infarction
|
Concept
|
Terminology as Topic
|
Concept
|
North America
|
Concept
|
Iodine Radioisotopes
|
Concept
|
Isoantibodies
|
Concept
|
Obesity
|
Concept
|
Neoplasm Recurrence, Local
|
Concept
|
Neoplasms
|
Concept
|
Joints
|
Concept
|
Plasma Exchange
|
Concept
|
Netherlands
|
Concept
|
Tissue Plasminogen Activator
|
Concept
|
Platelet Aggregation Inhibitors
|
Concept
|
Platelet Count
|
Concept
|
Plethysmography
|
Concept
|
Plethysmography, Impedance
|
Concept
|
Pleurisy
|
Concept
|
Middle Aged
|
Concept
|
Phlebography
|
Concept
|
Polysaccharides
|
Concept
|
Popliteal Vein
|
Concept
|
Models, Biological
|
Concept
|
Population Surveillance
|
Concept
|
Postoperative Care
|
Concept
|
Postoperative Complications
|
Concept
|
Postoperative Period
|
Concept
|
Molecular Weight
|
Concept
|
Morbidity
|
Concept
|
Morpholines
|
Concept
|
Practice Patterns, Physicians'
|
Concept
|
Physician's Role
|
Concept
|
Predictive Value of Tests
|
Concept
|
Prednisone
|
Concept
|
Pregnancy
|
Concept
|
Pregnancy Complications
|
Concept
|
Pregnancy Complications, Cardiovascular
|
Concept
|
Pregnancy Complications, Hematologic
|
Concept
|
Pilot Projects
|
Concept
|
Piperazines
|
Concept
|
Registries
|
Concept
|
Sampling Studies
|
Concept
|
Remission Induction
|
Concept
|
Research
|
Concept
|
Research Design
|
Concept
|
Respiration
|
Concept
|
Partial Thromboplastin Time
|
Concept
|
Respiratory Insufficiency
|
Concept
|
Schools, Public Health
|
Concept
|
Patient Admission
|
Concept
|
Patient Care Planning
|
Concept
|
Patient Discharge
|
Concept
|
Patient Education as Topic
|
Concept
|
Pediatrics
|
Concept
|
Retrospective Studies
|
Concept
|
Rhabdomyolysis
|
Concept
|
Self Administration
|
Concept
|
Sensitivity and Specificity
|
Concept
|
Severity of Illness Index
|
Concept
|
Sex Characteristics
|
Concept
|
Risk
|
Concept
|
Risk Factors
|
Concept
|
Sex Factors
|
Concept
|
Gonadal Steroid Hormones
|
Concept
|
Thiophenes
|
Concept
|
Thoracic Surgery
|
Concept
|
Thrombin
|
Concept
|
Thrombin Time
|
Concept
|
Thrombocytopenia
|
Concept
|
Thromboembolism
|
Concept
|
Thrombophlebitis
|
Concept
|
Thromboplastin
|
Concept
|
Thrombosis
|
Concept
|
Pulmonary Wedge Pressure
|
Concept
|
Surgical Procedures, Operative
|
Concept
|
Purpura, Thrombotic Thrombocytopenic
|
Concept
|
Pyrazoles
|
Concept
|
Time Factors
|
Concept
|
Pyridines
|
Concept
|
Pyridones
|
Concept
|
Pyrimidines
|
Concept
|
Pyrimidinones
|
Concept
|
Tomography, X-Ray Computed
|
Concept
|
Quality Assurance, Health Care
|
Concept
|
Surveys and Questionnaires
|
Concept
|
Technetium
|
Concept
|
Quinine
|
Concept
|
Rabbits
|
Concept
|
Radiography
|
Concept
|
Radionuclide Imaging
|
Concept
|
Random Allocation
|
Concept
|
Thiazoles
|
Concept
|
Thigh
|
Concept
|
Wounds and Injuries
|
Concept
|
Biomarkers
|
Concept
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
|
Concept
|
Recombinant Proteins
|
Concept
|
Recurrence
|
Concept
|
Splenectomy
|
Concept
|
Reproducibility of Results
|
Concept
|
Statistics as Topic
|
Concept
|
Helminth Proteins
|
Concept
|
Pulmonary Medicine
|
Concept
|
Focus Groups
|
Concept
|
Streptokinase
|
Concept
|
Structure-Activity Relationship
|
Concept
|
Cohort Studies
|
Concept
|
Multicenter Studies as Topic
|
Concept
|
Myocardial Ischemia
|
Concept
|
Immunoglobulins, Intravenous
|
Concept
|
Sulfones
|
Concept
|
Cost of Illness
|
Concept
|
Clinical Trials, Phase III as Topic
|
Concept
|
Treatment Outcome
|
Concept
|
Drug Monitoring
|
Concept
|
Vascular Resistance
|
Concept
|
Practice Guidelines as Topic
|
Concept
|
Ventilation-Perfusion Ratio
|
Concept
|
Cost Savings
|
Concept
|
Health Care Costs
|
Concept
|
Patient Satisfaction
|
Concept
|
Patient-Centered Care
|
Concept
|
Models, Economic
|
Concept
|
Vitamin K
|
Concept
|
Sample Size
|
Concept
|
Disease Progression
|
Concept
|
Chemoprevention
|
Concept
|
Ventricular Dysfunction, Right
|
Concept
|
Warfarin
|
Concept
|
Risk Assessment
|
Concept
|
Patient Selection
|
Concept
|
Ultrasonography, Doppler
|
Concept
|
Ultrasonography, Doppler, Color
|
Concept
|
Ultrasonography, Doppler, Duplex
|
Concept
|
Global Health
|
Concept
|
Oligonucleotides, Antisense
|
Concept
|
Critical Pathways
|
Concept
|
Postoperative Hemorrhage
|
Concept
|
Ventricular Dysfunction
|
Concept
|
Drug Costs
|
Concept
|
Purpura, Thrombocytopenic, Idiopathic
|
Concept
|
Stroke
|
Concept
|
Critical Illness
|
Concept
|
Venous Thrombosis
|
Concept
|
Enoxaparin
|
Concept
|
Dalteparin
|
Concept
|
Intracranial Hemorrhages
|
Concept
|
Rho(D) Immune Globulin
|
Concept
|
Neurosurgical Procedures
|
Concept
|
Orthopedic Procedures
|
Concept
|
Arthroplasty, Replacement, Hip
|
Concept
|
Arthroplasty, Replacement, Knee
|
Concept
|
Thrombophilia
|
Concept
|
Preoperative Care
|
Concept
|
Pressure
|
Concept
|
International Normalized Ratio
|
Concept
|
Primary Prevention
|
Concept
|
Probability
|
Concept
|
Perioperative Care
|
Concept
|
Prognosis
|
Concept
|
Prospective Studies
|
Concept
|
Hirudin Therapy
|
Concept
|
Prothrombin Time
|
Concept
|
Psychometrics
|
Concept
|
Advisory Committees
|
Concept
|
Public Health
|
Concept
|
Public Opinion
|
Concept
|
Pulmonary Artery
|
Concept
|
Pulmonary Embolism
|
Concept
|
Social Class
|
Concept
|
Socioeconomic Factors
|
Concept
|
Software
|
Concept
|
Specimen Handling
|
Concept
|
Triazoles
|
Concept
|
Early Detection of Cancer
|
Concept
|
Factor Xa Inhibitors
|
Concept
|
Ultrasonography
|
Concept
|
United States
|
Concept
|
Secondary Prevention
|
Concept
|
Urogenital System
|
Concept
|
Urokinase-Type Plasminogen Activator
|
Concept
|
Comorbidity
|
Concept
|
Thrombolytic Therapy
|
Concept
|
Factor VIIa
|
Concept
|
Factor XIa
|
Concept
|
Factor Xa
|
Concept
|
Bias
|
Concept
|
Causality
|
Concept
|
Body Mass Index
|
Concept
|
Incidence
|
Concept
|
Prevalence
|
Concept
|
Survival Rate
|
Concept
|
Multivariate Analysis
|
Concept
|
Confidence Intervals
|
Concept
|
Chi-Square Distribution
|
Concept
|
Linear Models
|
Concept
|
Logistic Models
|
Concept
|
Proportional Hazards Models
|
Concept
|
Odds Ratio
|
Concept
|
Survival Analysis
|
Concept
|
Case-Control Studies
|
Concept
|
Randomized Controlled Trials as Topic
|
Concept
|
Single-Blind Method
|
Concept
|
Biomedical Research
|
Concept
|
Tomography, Spiral Computed
|
Concept
|
Elective Surgical Procedures
|
Concept
|
Age of Onset
|
Concept
|
Age Distribution
|
Concept
|
Sex Distribution
|
Concept
|
Platelet Transfusion
|
Concept
|
Economics, Pharmaceutical
|
Concept
|
Evidence-Based Medicine
|
Concept
|
Polypharmacy
|
Concept
|
Disease Management
|
Concept
|
Thoracic Surgical Procedures
|
Concept
|
Comparative Effectiveness Research
|
Concept
|
Intention to Treat Analysis
|
Concept
|
Early Termination of Clinical Trials
|
Concept
|
Electronic Health Records
|
Concept
|
Postthrombotic Syndrome
|
Concept
|
National Cancer Institute (U.S.)
|
Concept
|
National Heart, Lung, and Blood Institute (U.S.)
|
Concept
|
Venous Thromboembolism
|
Concept
|
Chills
|
Concept
|
Drug-Related Side Effects and Adverse Reactions
|
Concept
|
Research Report
|
Concept
|
Asymptomatic Diseases
|
Concept
|
Acute Kidney Injury
|
Concept
|
Kaplan-Meier Estimate
|
Concept
|
ADAM Proteins
|
Concept
|
Young Adult
|
Concept
|
Chemical and Drug Induced Liver Injury
|
Concept
|
Antibodies, Monoclonal, Humanized
|
Concept
|
Acenocoumarol
|
Concept
|
Equivalence Trials as Topic
|
Concept
|
Arginine
|
Concept
|
Arm
|
Concept
|
Aspirin
|
Concept
|
Atrial Fibrillation
|
Concept
|
Attitude of Health Personnel
|
Concept
|
Autoimmune Diseases
|
Concept
|
Awareness
|
Concept
|
Cerebral Hemorrhage
|
Concept
|
Brain Ischemia
|
Concept
|
Ischemic Attack, Transient
|
Concept
|
Cerebrovascular Disorders
|
Concept
|
Chemical Warfare
|
Concept
|
Chemical Warfare Agents
|
Concept
|
Child
|
Concept
|
Child, Preschool
|
Concept
|
Diagnosis, Differential
|
Concept
|
Diagnostic Imaging
|
Concept
|
Disaster Planning
|
Concept
|
Follow-Up Studies
|
Concept
|
Forecasting
|
Concept
|
France
|
Concept
|
Gravity Suits
|
Concept
|
Gangrene
|
Concept
|
Gases
|
Concept
|
Gastrointestinal Diseases
|
Concept
|
Hypertension, Pulmonary
|
Concept
|
Hypoglycemia
|
Concept
|
Immobilization
|
Concept
|
Immunity, Maternally-Acquired
|
Concept
|
Immunosuppressive Agents
|
Concept
|
Indicators and Reagents
|
Concept
|
Infant
|
Concept
|
Infant, Newborn
|
Concept
|
Medical Oncology
|
Concept
|
Medical Records
|
Concept
|
Metalloendopeptidases
|
Concept
|
Methods
|
Concept
|
Oklahoma
|
Concept
|
Oligonucleotides
|
Concept
|
Oligosaccharides
|
Concept
|
Ontario
|
Concept
|
Organothiophosphorus Compounds
|
Concept
|
Outpatients
|
Academic Article
|
Clinical decisions in idiopathic thrombocytopenic purpura.
|
Academic Article
|
The economic impact of treating deep vein thrombosis with low-molecular-weight heparin: outcome of therapy and health economy aspects.
|
Academic Article
|
Venous thromboembolic disease.
|
Academic Article
|
Sensitivity and specificity of ultrasonography in the diagnosis of upper extremity deep vein thrombosis: a systematic review.
|
Academic Article
|
ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients.
|
Academic Article
|
Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.
|
Academic Article
|
Initial management of immune thrombocytopenic purpura in adults: a randomized controlled trial comparing intermittent anti-D with routine care.
|
Academic Article
|
Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery.
|
Academic Article
|
The economics of venous thromboembolism prophylaxis: a primer for clinicians.
|
Academic Article
|
Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial.
|
Academic Article
|
A cost-effectiveness analysis of fondaparinux sodium compared with enoxaparin sodium as prophylaxis against venous thromboembolism: use in patients undergoing major orthopaedic surgery.
|
Academic Article
|
Chemical (VX) terrorist threat: public knowledge, attitudes, and responses.
|
Academic Article
|
Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
|
Academic Article
|
Idraparinux versus standard therapy in the treatment of deep venous thrombosis in cancer patients: a subgroup analysis of the Van Gogh DVT trial.
|
Academic Article
|
Oral rivaroxaban for symptomatic venous thromboembolism.
|
Academic Article
|
Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials.
|
Academic Article
|
Apixaban for extended treatment of venous thromboembolism.
|
Academic Article
|
Edoxaban for the long-term treatment of venous thromboembolism: rationale and design of the Hokusai-venous thromboembolism study--methodological implications for clinical trials.
|
Academic Article
|
Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies.
|
Academic Article
|
Thrombosis: a major contributor to global disease burden.
|
Academic Article
|
Thrombosis: a major contributor to global disease burden.
|
Academic Article
|
On World Thrombosis Day.
|
Academic Article
|
The design and implementation of a new surveillance system for venous thromboembolism using combined active and passive methods.
|
Academic Article
|
Global Burden of Thrombosis: Epidemiologic Aspects.
|
Academic Article
|
Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study.
|
Academic Article
|
Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study.
|
Academic Article
|
Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists.
|
Academic Article
|
Clinical Impact and Course of Anticoagulant-Related Major Bleeding in Cancer Patients.
|
Academic Article
|
Risk Scores for Occult Cancer in Patients with Venous Thromboembolism: A Post Hoc Analysis of the Hokusai-VTE Study.
|
Academic Article
|
Thromboprophylaxis with Rivaroxaban in Acutely Ill Medical Patients with Renal Impairment: Insights from the MAGELLAN and MARINER Trials.
|
Academic Article
|
Prevention of Venous Thromboembolism in Hospitalized Medically Ill Patients: A U.S. Perspective.
|
Academic Article
|
Hemorrhagic complications of anticoagulant treatment.
|
Academic Article
|
Optimal therapeutic level of heparin therapy in patients with venous thrombosis.
|
Academic Article
|
Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis.
|
Academic Article
|
Pharmacokinetics and dynamics of heparin in patients with proximal vein thrombosis.
|
Academic Article
|
The current status and future directions of impedance cardiography in ICU.
|
Academic Article
|
Anticoagulant therapy for venous thromboembolism.
|
Academic Article
|
Hemorrhagic complications of long-term anticoagulant therapy.
|
Academic Article
|
The low-probability lung scan. A need for change in nomenclature.
|
Academic Article
|
Impedance plethysmography for suspected deep-vein thrombosis.
|
Academic Article
|
Effect of treatment with low-dose warfarin-aspirin on activated factor VII.
|
Academic Article
|
Preventing systemic embolism in patients with abnormal ventricular function.
|
Academic Article
|
Cost effectiveness of diagnosis of deep vein thrombosis in symptomatic patients.
|
Academic Article
|
Pulmonary embolism among patients with a nearly normal ventilation/perfusion lung scan.
|
Academic Article
|
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology.
|
Academic Article
|
The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy. The emerging theme of delayed recurrence.
|
Academic Article
|
Low molecular weight heparin for the prevention and treatment of venous thromboembolism.
|
Academic Article
|
The clinical validity of normal compression ultrasonography in outpatients suspected of having deep venous thrombosis.
|
Academic Article
|
Heparin and low molecular weight heparin for treatment of acute pulmonary embolism.
|
Academic Article
|
Diagnosis of pulmonary embolism.
|
Academic Article
|
Drug-induced thrombocytopenia.
|
Academic Article
|
The diagnostic approach to acute venous thromboembolism. Clinical practice guideline. American Thoracic Society.
|
Academic Article
|
Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacement.
|
Academic Article
|
Measuring the outcomes and pharmacoeconomic consequences of venous thromboembolism prophylaxis in major orthopaedic surgery.
|
Academic Article
|
Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer.
|
Academic Article
|
Self-managed long-term low-molecular-weight heparin therapy: the balance of benefits and harms.
|
Academic Article
|
Idraparinux versus standard therapy for venous thromboembolic disease.
|
Academic Article
|
Extended prophylaxis of venous thromboembolism with idraparinux.
|
Academic Article
|
The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries.
|
Academic Article
|
Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement. A randomised double-blind dose-response study.
|
Academic Article
|
Apixaban versus enoxaparin for thromboprophylaxis after hip replacement.
|
Academic Article
|
Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials.
|
Academic Article
|
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism.
|
Academic Article
|
Apixaban after hip or knee arthroplasty versus enoxaparin: efficacy and safety in key clinical subgroups.
|
Academic Article
|
Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation Study.
|
Academic Article
|
On World Thrombosis Day.
|
Academic Article
|
Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial.
|
Academic Article
|
Diversity and severity of adverse reactions to quinine: A systematic review.
|
Academic Article
|
The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications.
|
Academic Article
|
Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE: A Benefit-Risk Analysis of EINSTEIN-Extension.
|
Academic Article
|
The Value of Prevention Research Centers: Breaking New Ground in Prevention Research.
|
Academic Article
|
New paradigms in venous thromboprophylaxis of medically ill patients.
|
Academic Article
|
Direct Oral Anticoagulants for Pulmonary Embolism: Importance of Anatomical Extent.
|
Academic Article
|
Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post-hoc analysis of the Hokusai-VTE Cancer study.
|
Academic Article
|
Extended vs. standard-duration thromboprophylaxis in acutely ill medical patients: A systematic review and meta-analysis.
|
Academic Article
|
Clinical implications of incidental venous thromboembolism in cancer patients.
|
Academic Article
|
Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study.
|
Academic Article
|
Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study.
|
Academic Article
|
Corrigendum to "Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study" [Thromb. Res. vol. 185, January 2020, pages 13-19].
|
Academic Article
|
Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients.
|
Academic Article
|
Incidence of Venous Thromboembolism in a Racially Diverse Population of Oklahoma County, Oklahoma.
|
Academic Article
|
Heparin therapy for venous thrombosis and pulmonary embolism.
|
Academic Article
|
The diagnosis of clinically suspected venous thrombosis.
|
Academic Article
|
Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.
|
Academic Article
|
Chronic idiopathic thrombocytopenic purpura.
|
Academic Article
|
Safety and anticoagulation effect of a low-dose combination of warfarin and aspirin in clinically stable coronary artery disease. Coumadin Aspirin Reinfarction (CARS) Pilot Study Group.
|
Academic Article
|
Risks for major bleeding from thrombolytic therapy in patients with acute pulmonary embolism. Consideration of noninvasive management.
|
Academic Article
|
Aging and heparin-related bleeding.
|
Academic Article
|
Monitoring low-dose warfarin therapy by a central laboratory and implications for clinical trials and patient care. The Coumadin Aspirin Reinfarction (CARS) Pilot Study Group.
|
Academic Article
|
Idiopathic thrombocytopenic purpura: A concise summary of the pathophysiology and diagnosis in children and adults.
|
Academic Article
|
Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis.
|
Academic Article
|
Idiopathic thrombocytopenic purpura: a guideline for diagnosis and management of children and adults. American Society of Hematology.
|
Academic Article
|
Different effects of heparin in males and females.
|
Academic Article
|
Idiopathic thrombocytopenic purpura: diagnosis and management.
|
Academic Article
|
Low-molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism. American-Canadian Thrombosis Study Group.
|
Academic Article
|
Sensitivity and specificity of helical computed tomography in the diagnosis of pulmonary embolism: a systematic review.
|
Academic Article
|
Predictive value of compression ultrasonography for deep vein thrombosis in symptomatic outpatients: clinical implications of the site of vein noncompressibility.
|
Academic Article
|
Self-reported diagnostic and management strategies in childhood idiopathic thrombocytopenic purpura: results of a survey of practicing pediatric hematology/oncology specialists.
|
Academic Article
|
Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review.
|
Academic Article
|
Helical computed tomography and magnet resonance imaging: diagnosis of pulmonary embolism in symptomatic patients.
|
Academic Article
|
Clinical utility of D-dimer in patients with suspected pulmonary embolism and nondiagnostic lung scans or negative CT findings.
|
Academic Article
|
Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
|
Academic Article
|
Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
|
Academic Article
|
Duration of warfarin in pulmonary embolism.
|
Academic Article
|
American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.
|
Academic Article
|
Exclusion of first-episode deep-vein thrombosis after-hours using D-dimer.
|
Academic Article
|
Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery.
|
Academic Article
|
Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
|
Academic Article
|
Challenges in the diagnosis of acute pulmonary embolism.
|
Academic Article
|
Pulmonary embolism in outpatients with pleuritic chest pain.
|
Academic Article
|
Apixaban or enoxaparin for thromboprophylaxis after knee replacement.
|
Academic Article
|
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial.
|
Academic Article
|
Hemorrhagic complications of long-term anticoagulant therapy.
|
Academic Article
|
Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis.
|
Academic Article
|
Epidemiology and pathogenesis of venous thrombosis.
|
Academic Article
|
Clinical features and diagnosis of venous thrombosis.
|
Academic Article
|
Diagnosis of pulmonary embolism.
|
Academic Article
|
Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial.
|
Academic Article
|
Oral apixaban for the treatment of acute venous thromboembolism.
|
Academic Article
|
Dose reduction of edoxaban preserves efficacy and safety for the treatment of venous thromboembolism. An analysis of the randomised, double-blind HOKUSAI VTE trial.
|
Academic Article
|
RE-COVERY DVT/PE: Rationale and design of a prospective observational study of acute venous thromboembolism with a focus on dabigatran etexilate.
|
Academic Article
|
Impact of World Thrombosis Day campaign.
|
Academic Article
|
Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study.
|
Academic Article
|
Physician-guided treatment compared with a heparin protocol for deep vein thrombosis.
|
Academic Article
|
Modified IMPROVE VTE Risk Score and Elevated D-Dimer Identify a High Venous Thromboembolism Risk in Acutely Ill Medical Population for Extended Thromboprophylaxis.
|
Academic Article
|
A noninvasive strategy for the treatment of patients with suspected pulmonary embolism.
|
Academic Article
|
Impedance plethysmography and DVT diagnosis.
|
Academic Article
|
Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective.
|
Academic Article
|
Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective.
|
Academic Article
|
Underuse of venous thromboembolism prophylaxis for general surgery patients: physician practices in the community hospital setting.
|
Academic Article
|
Hemorrhagic complications of anticoagulant treatment.
|
Academic Article
|
Drug-induced thrombocytopenia: a systematic review of published case reports.
|
Academic Article
|
Withholding treatment in patients with acute pulmonary embolism who have a high risk of bleeding and negative serial noninvasive leg tests.
|
Academic Article
|
Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review.
|
Academic Article
|
Negative D-dimer result to exclude recurrent deep venous thrombosis: a management trial.
|
Academic Article
|
A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study.
|
Academic Article
|
Design of the REVEAL registry for US patients with pulmonary arterial hypertension.
|
Academic Article
|
Surveillance for deep vein thrombosis and pulmonary embolism: recommendations from a national workshop.
|
Academic Article
|
A dose-finding study with TAK-442, an oral factor Xa inhibitor, in patients undergoing elective total knee replacement surgery.
|
Academic Article
|
Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.
|
Academic Article
|
Edoxaban for treatment of venous thromboembolism in patients with cancer. Rationale and design of the Hokusai VTE-cancer study.
|
Academic Article
|
Early time courses of recurrent thromboembolism and bleeding during apixaban or enoxaparin/warfarin therapy. A sub-analysis of the AMPLIFY trial.
|
Academic Article
|
Clinical impact and course of major bleeding with edoxaban versus vitamin K antagonists.
|
Academic Article
|
Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial.
|
Academic Article
|
Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists. An individual patient data meta-analysis.
|
Academic Article
|
Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study.
|
Academic Article
|
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.
|
Academic Article
|
Impact of age, comorbidity, and polypharmacy on the efficacy and safety of edoxaban for the treatment of venous thromboembolism: An analysis of the randomized, double-blind Hokusai-VTE trial.
|
Academic Article
|
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness.
|
Academic Article
|
Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists.
|
Academic Article
|
The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations.
|
Academic Article
|
Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial.
|
Academic Article
|
Randomized phase 2 trial comparing JNJ-9375, a thrombin-directed antibody, with apixaban for prevention of venous thrombosis.
|
Academic Article
|
Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial.
|
Academic Article
|
Treatment of Cancer-Associated Venous Thromboembolism with Low-Molecular-Weight Heparin or Direct Oral Anticoagulants: Patient Selection, Controversies, and Caveats.
|
Academic Article
|
Effectiveness of intermittent pneumatic leg compression for preventing deep vein thrombosis after total hip replacement.
|
Academic Article
|
Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis.
|
Academic Article
|
Diagnosis and management of pulmonary thromboembolism.
|
Academic Article
|
Clinical validity of a normal perfusion lung scan in patients with suspected pulmonary embolism.
|
Academic Article
|
Serial impedance plethysmography in pregnant patients with clinically suspected deep-vein thrombosis. Clinical validity of negative findings.
|
Academic Article
|
Predicting the daily prothrombin time response to warfarin.
|
Academic Article
|
Prophylaxis of venous thromboembolic disease following hip and knee surgery.
|
Academic Article
|
Prophylaxis of venous thromboembolism. An overview.
|
Academic Article
|
The diagnosis of clinically suspected pulmonary embolism. Practical approaches.
|
Academic Article
|
Risk of haemorrhage associated with long term anticoagulant therapy.
|
Academic Article
|
Methodological guidelines for clinical trials evaluating new therapeutic approaches in bone and joint surgery.
|
Academic Article
|
Diagnostic value of ventilation-perfusion lung scanning in patients with suspected pulmonary embolism.
|
Academic Article
|
Hemorrhagic complications of anticoagulant treatment.
|
Academic Article
|
A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation.
|
Academic Article
|
Duplex ultrasonography for the detection of deep vein thrombi after total hip or knee arthroplasty.
|
Academic Article
|
Long-term oral anticoagulant therapy for coronary artery disease.
|
Academic Article
|
Duration of anticoagulant treatment for venous thrombosis.
|
Grant
|
THROMBOSIS: ETIOLOGY, RISK FACTORS AND TREATMENT
|
Grant
|
OU Human Research Protection Program, Year 2
|
Grant
|
OU Developmental Center for Injury Prevention Research
|
Grant
|
ACTIVE SURVEILLANCE FOR VENOUS THROMBOEMBOLISM IN A RACIALLY DIVERSE POPULATION
|
Academic Article
|
Association Between Asymptomatic Proximal Deep Vein Thrombosis and Mortality in Acutely Ill Medical Patients.
|
Academic Article
|
Benefit-Risk of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness: Pooled Analysis From MAGELLAN and MARINER.
|
Academic Article
|
Milvexian for the Prevention of Venous Thromboembolism.
|
Academic Article
|
Abelacimab for Prevention of Venous Thromboembolism.
|
Academic Article
|
Rivaroxaban for extended thromboprophylaxis in acutely ill medical patients 75 years of age or older.
|
Academic Article
|
Risk of Severe Bleeding With Extended Rivaroxaban to Prevent Venous Thromboembolism in Acute Medically Ill Patients With Bronchiectasis.
|
Academic Article
|
Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Systematic Review and Meta-analysis.
|
Academic Article
|
Association of Bleeding Severity With Mortality in Extended Thromboprophylaxis of Medically Ill Patients in the MAGELLAN and MARINER Trials.
|
Academic Article
|
Cancer-associated venous thromboembolism: Incidence and features in a racially diverse population.
|
Academic Article
|
Benefit-Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness.
|
Academic Article
|
Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction.
|
Academic Article
|
Anticoagulant Therapy for Mechanical Heart Valves - Unmet Need Persists.
|